Literature DB >> 29406956

Diagnosis and treatment of catheter-related bloodstream infection: Clinical guidelines of the Spanish Society of Infectious Diseases and Clinical Microbiology and (SEIMC) and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC).

F Chaves1, J Garnacho-Montero2, J L Del Pozo3, E Bouza4, J A Capdevila5, M de Cueto6, M Á Domínguez7, J Esteban8, N Fernández-Hidalgo9, M Fernández Sampedro10, J Fortún11, M Guembe12, L Lorente13, J R Paño14, P Ramírez15, M Salavert16, M Sánchez17, J Vallés18.   

Abstract

Catheter-related bloodstream infections (CRBSI) constitute an important cause of hospital-acquired infection associated with morbidity, mortality, and cost. The aim of these guidelines is to provide updated recommendations for the diagnosis and management of CRBSI in adults. Prevention of CRBSI is excluded. Experts in the field were designated by the two participating Societies (the Spanish Society of Infectious Diseases and Clinical Microbiology and [SEIMC] and the Spanish Society of Spanish Society of Intensive and Critical Care Medicine and Coronary Units [SEMICYUC]). Short-term peripheral venous catheters, non-tunneled and long-term central venous catheters, tunneled catheters and hemodialysis catheters are covered by these guidelines. The panel identified 39 key topics that were formulated in accordance with the PICO format. The strength of the recommendations and quality of the evidence were graded in accordance with ESCMID guidelines. Recommendations are made for the diagnosis of CRBSI with and without catheter removal and of tunnel infection. The document establishes the clinical situations in which a conservative diagnosis of CRBSI (diagnosis without catheter removal) is feasible. Recommendations are also made regarding empirical therapy, pathogen-specific treatment (coagulase-negative staphylococci, Staphylococcus aureus, Enterococcus spp., Gram-negative bacilli, and Candida spp.), antibiotic lock therapy, diagnosis and management of suppurative thrombophlebitis and local complications.
Copyright © 2017 Elsevier España, S.L.U. y SEMICYUC. All rights reserved.

Entities:  

Keywords:  Antibiotic; Antibioticoterapia; Bacteremia; Bacteriemia; Bacteriemia relacionada con catéter; Blood cultures; Catheter-related bloodstream infection; Guidelines; Guía de práctica clínica; Hemocultivos

Mesh:

Substances:

Year:  2018        PMID: 29406956     DOI: 10.1016/j.medin.2017.09.012

Source DB:  PubMed          Journal:  Med Intensiva (Engl Ed)        ISSN: 2173-5727


  20 in total

1.  ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.

Authors:  Ignacio Martin-Loeches; Massimo Antonelli; Manuel Cuenca-Estrella; George Dimopoulos; Sharon Einav; Jan J De Waele; Jose Garnacho-Montero; Souha S Kanj; Flavia R Machado; Philippe Montravers; Yasser Sakr; Maurizio Sanguinetti; Jean-Francois Timsit; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2019-03-25       Impact factor: 17.440

2.  Treatment of central line-associated bloodstream infections.

Authors:  Jérémy Guenezan; Bertrand Drugeon; Nicolas Marjanovic; Olivier Mimoz
Journal:  Crit Care       Date:  2018-11-16       Impact factor: 9.097

Review 3.  Practical approach to the management of catheter-related bloodstream infection.

Authors:  M L Cantón-Bulnes; J Garnacho-Montero
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

4.  Comment on: Bacteremia in pediatric patients with hematopoietic stem transplantation.

Authors:  Antonio Vaz de Macedo
Journal:  Hematol Transfus Cell Ther       Date:  2020-01-29

5.  Bacteremia in pediatric patients with hematopoietic stem cell transplantation.

Authors:  Paola Perez; Jaime Patiño; Mayra Estacio; Jessica Pino; Eliana Manzi; Diego Medina
Journal:  Hematol Transfus Cell Ther       Date:  2019-08-11

6.  The timing of continuous renal replacement therapy initiation in sepsis-associated acute kidney injury in the intensive care unit: the CRTSAKI Study (Continuous RRT Timing in Sepsis-associated AKI in ICU): study protocol for a multicentre, randomised controlled trial.

Authors:  Wei-Yan Chen; Li-Hua Cai; Zhen-Hui Zhang; Li-Li Tao; Yi-Chao Wen; Zhi-Bo Li; Li Li; Yun Ling; Jian-Wei Li; Rui Xing; Xue-Yan Liu; Zhuan-di Lin; Zhe-Tong Deng; Shou-Hong Wang; Qin-Han Lin; Dun-Rong Zhou; Zhi-Jie He; Xu-Ming Xiong
Journal:  BMJ Open       Date:  2021-02-19       Impact factor: 2.692

7.  [Chinese guidelines for the clinical application of antibacterial drugs for agranulocytosis with fever (2020)].

Authors: 
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14

8.  [Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU].

Authors:  Ángel Estella; Pablo Vidal-Cortés; Alejandro Rodriguez; David Andaluz Ojeda; Ignacio Martin-Loeches; Emili Díaz; Borja Suberviola; María Pilar Gracia Arnillas; Mercedes Catalán González; Francisco Álvarez-Lerma; Paula Ramirez; Xavier Nuvials; Marcio Borges Sa; Rafael Zaragoza
Journal:  Med Intensiva (Engl Ed)       Date:  2021-04-30

9.  Update in Infectious Diseases 2019.

Authors:  F J Candel; C M Rico; I Díaz de la Torre; B Laguna; J Martínez-Jordán; S Medrano; M C Escobar-Porcel; A López-Delgado; L López-González; J M Viñuela-Prieto; M Matesanz; J González Del Castillo; A Arribi
Journal:  Rev Esp Quimioter       Date:  2019-09       Impact factor: 1.553

10.  Nosocomial infections associated to COVID-19 in the intensive care unit: clinical characteristics and outcome.

Authors:  Tommaso Bardi; Vicente Pintado; Maria Gomez-Rojo; Rosa Escudero-Sanchez; Amal Azzam Lopez; Yolanda Diez-Remesal; Nilda Martinez Castro; Patricia Ruiz-Garbajosa; David Pestaña
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2021-01-03       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.